Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report

BACKGROUND: Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacella, Fernanda, Agostinelli, Enzo, Carlesimo, Sandra Cinzia, Nebbioso, Marcella, Secondi, Roberto, Forastiere, Michele, Pacella, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062904/
https://www.ncbi.nlm.nih.gov/pubmed/27733187
http://dx.doi.org/10.1186/s13256-016-1077-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062904/
https://www.ncbi.nlm.nih.gov/pubmed/27733187
http://dx.doi.org/10.1186/s13256-016-1077-2

Ejemplares similares